Description |
potassium voltage-gated channel modifier subfamily S member 3 |
potassium voltage-gated channel subfamily B member 1 |
Image |
No pdb structure |
No pdb structure |
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Diastolic blood pressure ( 30224653)
- Height ( 28552196)
- Obesity-related traits ( 23251661)
- Schizophrenia ( 25056061 29483656)
- White matter hyperintensity burden ( 25663218)
|
Interacting Genes |
1 interacting genes:
KCNB1
|
19 interacting genes:
CALM1
KCNB2
KCNE5
KCNG1
KCNG2
KCNG3
KCNG4
KCNH1
KCNS3
KCNV1
KCNV2
NEDD4L
PTK2
PTPRE
SNAP25
SRC
STX1A
VAPA
VAPB
|
Entrez ID |
3790 |
3745 |
HPRD ID |
04865 |
08983 |
Ensembl ID |
ENSG00000170745
|
ENSG00000158445
|
Uniprot IDs |
Q9BQ31
|
Q14721
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|